Cancer Focus Fund

Venture Capital Active United States
Last updated 2026-06-18
Portfolio
3
in our dataset
Rounds participated
3
Rounds led
1
Rounds' value
$57.0M
total disclosed, rounds participated
Stages
—

Portfolio · 3

Starget Pharma
Novel Somatostatin-based Targeted Therapy Platform
Led ★ 1 round $5.1M committed Latest: 2024-10
Nectin Therapeutics
Next-generation Immunotherapy Agents
1 round $5.4M committed Latest: 2022-03
KAHR Medical
Fusion Proteins for Treating Cancer and Autoimmune Diseases
1 round $46.5M committed Latest: 2021-06

Investment activity

Portfolio by sector

Health Tech & Life Sciences3

Q&A

What is Cancer Focus Fund's primary investment focus?
Cancer Focus Fund primarily invests in the Health Tech & Life Sciences sector, with all three of its portfolio companies operating in this area.
Can you name some of Cancer Focus Fund's portfolio companies?
Cancer Focus Fund's portfolio includes KAHR Medical, which develops fusion proteins for treating cancer and autoimmune diseases.
What is the investment range for Cancer Focus Fund?
Cancer Focus Fund typically invests between $5.1M and $46.5M per round.
When was Cancer Focus Fund most active in making new investments?
Cancer Focus Fund has made new portfolio investments in June 2021, March 2022, and October 2024.
Has Cancer Focus Fund invested in early-stage companies?
Yes, Cancer Focus Fund has participated in a Seed round and an A Round investment.
What is the most recent investment by Cancer Focus Fund?
Cancer Focus Fund made an investment in October 2024, which was a new portfolio company addition.